Monday, December 5, 2016

BRIEF-Daiichi Sankyo presents Phase 1 Data for MDM2 Inhibitor DS-3032 in AML, MDS

* Press release - Daiichi Sankyo Presents Phase 1 Data for

MDM2 Inhibitor DS-3032 in Acute Myeloid Leukemia and

Myelodysplastic Syndrome at the 58th Annual Meeting Of The

American Society Of Hematology

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)